cycloastragenol has been researched along with eosine yellowish-(ys) in 1 studies
| Studies (cycloastragenol) | Trials (cycloastragenol) | Recent Studies (post-2010) (cycloastragenol) | Studies (eosine yellowish-(ys)) | Trials (eosine yellowish-(ys)) | Recent Studies (post-2010) (eosine yellowish-(ys)) |
|---|---|---|---|---|---|
| 62 | 0 | 55 | 2,860 | 49 | 1,195 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Gayyar, MMH; Almasri, D; Bagalagel, A; Bakhsh, HT; Diri, R; Kutbi, HI; Noor, A | 1 |
1 other study(ies) available for cycloastragenol and eosine yellowish-(ys)
| Article | Year |
|---|---|
The therapeutic effects of cycloastragenol in ulcerative colitis by modulating SphK/MIP-1α/miR-143 signalling.
Topics: Animals; bcl-2-Associated X Protein; Chemokine CCL3; Colitis, Ulcerative; Eosine Yellowish-(YS); Female; Male; MicroRNAs; NF-kappa B; Phosphotransferases (Alcohol Group Acceptor); Rats; Sapogenins; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha | 2022 |